During the projected period, it is anticipated that rising rates of cancers like lung cancer, breast cancer, and others will fuel market expansion. For instance, a 2018 report from the World Health Organisation indicated that cancer was the second-leading cause of mortality worldwide and was responsible for over 9.6 million deaths in 2018. The market is anticipated to increase as a result of leading firms focusing on inorganic tactics like mergers and acquisitions to introduce innovative tailored cell treatments for the treatment of cancer patients. For instance, Pfizer, Inc. announced its merger with Allogene in 2018 in order to create a CAR-T cell therapy that is currently under examination. The worldwide cancer cell market is anticipated to be driven by key businesses concentrating on regulatory approvals for novel treatments of malignancies such as breast cancer and others. Due to prominent companies' emphasis on R&D for the treatment of various malignancies, including metastatic urothelial carcinoma, the market is anticipated to increase significantly throughout the forecast period. During the projected period, North America is anticipated to have a dominating position in the global cancer cell market.
Coherent Market Insights predicts that the market for Cancer Cells is anticipated to reach a value of US$ 8,525.5 million in 2020 and grow at a CAGR of 8.20% from 2020 to 2027.
Key Companies in the Cancer Cell Industry:
1. Bio-Rad Laboratories Inc.
The firm was founded in 1952 and is based in California, United States. The business produces and sells analytical instruments, clinical diagnostics, and equipment for use in life science research. Products and systems from Bio-Rad Laboratories are used to separate complicated chemical and biological materials as well as to recognise, examine, and purify their constituent parts. In March 2021, Bio-Rad and Roche announced a partnership.
2. Siemens Healthineers AG
The firm was established in 1847 and is located in Munich and Berlin, Germany. The Company has made significant investments in automation, electrification, and digitization. A strategic alliance between Siemens and the Swedish producer of electric commercial trucks, Volta Trucks, was announced in October 2022. In October 2021, Siemens paid an undisclosed sum to acquire Wattsense, a provider of IoT hardware and software for buildings.
3. GE Healthcare
The company was founded in 1892 and is located in Chicago, Illinois, U.S. The company supplies a variety of laboratory and medical equipment, including detectors, tracks, dispensers, imagers, screens, recording devices, analyzers, separators, and other items, to the global medical and medical research industries. It was revealed in February 2023 that GE HealthCare had purchased Caption Health, a maker of AI-based medical technologies with its headquarters in San Mateo, for an undisclosed price.
4. Thermo Fisher Scientific
The business was started in 1956 and has its headquarters in Waltham, Massachusetts, United States. Thermo Fisher Scientific, Inc. produces chemicals, consumables, and scientific equipment. The acquisition of PPD, Inc. by Thermo Fisher Scientific was announced in April 2021. Thermo Fisher Scientific said in January 2021 that it had purchased Henogen SA, a producer of viral vectors based in Belgium, from Groupe Novasep SAS for €725 million in cash.
5. Abbott Laboratories
The company was started in 1888 and is based in Chicago, Illinois, United States. The business finds, creates, produces, and markets a diverse range of healthcare goods and services. Pharmaceuticals, nutritional, diagnostic, and vascular items are among the offerings of the company. Lingo, a series of consumer biowearable sensors that collects a variety of biological measurements to optimise exercise and dietary plans, was released by Abbott in January 2022.
6. Novartis International AG,
The company was founded in March 1996 and has its main offices in Basel, Switzerland, and Cambridge, Massachusetts, in the United States. Novartis provides coverage for all types of medications, including authorization, over-the-counter, immunisations, diagnostics, eyewear, and veterinary care. Through its firms, Novartis engages in a number of direct activities, including managing, advertising, operations, and research.
7. Autolus Therapeutics
The company was started in 2014 and is based in United Kingdom. The business creates cell treatments for the treatment of cancer and conducts business as a biopharmaceutical company. A CAR T cell treatment firm called Autolus creates cutting-edge autologous T cell therapies with the potential to have a profoundly positive impact on patients' lives.
Definition: When a succession of mutations cause a normal cell to continue to expand and divide uncontrollably, the result is the development of cancerous cells, which is how cancer cells differ from normal cells.
